LAUSANNE, SWITZERLAND (PRWEB) January 11, 2021 -- Biospectal, the remote patient monitoring and biosensing software company, today announced the public beta
Democratizing and providing easy access to blood pressure monitoring to people worldwide enables improved treatment and impacts medical outcomes. Biospectal OptiBP is a prime example of a broader transition toward remote patient monitoring that moves the clinical functions and capability out of the professional setting to the ‘point of patient’ where they live. Biospectal’s patented OptiBP technology replaces the antiquated traditional blood pressure cuff and provides medical-grade blood pressure measurement and management at the ‘point of patient’ in the time it takes to download an app — without the need for yet another wearable device or additional bulky hardware. Health-conscious consumers and hypertensive patients worldwide can now contribute to, and be involved in their health outcomes in a way that hasn’t existed previously.